http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1114541-T1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07707223721223ce27dfca225f7d9c30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b584f775702472369d59ef33b9631af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4453700dc6ee0cab9a772b4255c20d47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68c4f7309fa68dc00fbc22f8053042d8 |
| publicationDate | 2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CY-1114541-T1 |
| titleOfInvention | Citrate 9E-15- (2-Pyrrolidin-1-yl-ethoxy) -7,12,25-TRIOAXA-19,21,24-TRIACEA-TETRACYCL [18.3.1.1 (2.5) .1 (14.18) ]] SUNDAY-1 (24), 2,4,9,14,16,18 (26), 20,22-NENENIUM |
| abstract | The present invention relates to specific salts of 9E-15- (2-pyrrolidin-1-yl-ethoxy) -7,12,25-trioxa-19,21,24-triaza-tetracyclo [18.3.1.1 (2.5). 1 (14,18)] six hundred-1 (24), 2,4,9,14,16,18 (26), 20,22-nonenone (Compound I), which have been found to possess improved properties. In particular the present invention relates to the citrate of this compound. The invention also relates to pharmaceutical compositions containing the citrate salt and methods of using the citrate salt in the treatment of certain medical conditions. |
| priorityDate | 2009-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348 |
Total number of triples: 16.